Followers | 62 |
Posts | 4507 |
Boards Moderated | 0 |
Alias Born | 02/09/2012 |
Thursday, October 30, 2014 7:11:23 PM
BS! Apples and Oranges. Literally. Apple invested half a bill in GTAT to help ramp up their ability to produce Sapphire for Apple. Apple paid 20 mill for the rights to LQMT's portfolio and has maybe(according to AP) invested 100's of millions more in researching and developing amorphous alloy for potential use in Apples own products. Potentially to someday use amorphous alloy parts manufactured by a manufacturer of Apples choosing. And Apple can call the amorphous alloy parts anything they want. Apple doesn't owe anything more to LQMT best of my knowledge. Although the partnership must be beneficial to Apple in some way, since they keep extending it. Or maybe Steipp is just great at begging and Apple agrees to the extensions to get rid of this pesky annoyance.
Was it really a bad idea to partner with the potential Sapphire supplier? Not in my opinion. But, obviously for whatever reason the "gamble" didn't pan out. So......... Now we know. 1/2 billion flip of the coin and poof. Everyone loses. But they gave it a shot and it's sad because of the jobs it would have created in Murica. Maybe next time.
Would Apple extend that kind of gamble of using LQMT to manufacture for them if they decide to someday use BMG? Seriously? Do you really believe this junk could ever be capable of delivering potentially 100's of millions of parts for iProducts per year? Why?
Seriously. Get frikkin real.
Just my opinion and best of luck.
Let's keep it civil and understand that this is a forum of mostly amateur opinions. I am not here to give advice or argue. The best way to get rid of trolls is by using the ignore feature. And if you don't like what I say feel free to ignore me. Thanx.
Recent LQMT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 10:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 10:26:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 08:41:42 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM